Doctors Holding Free Pre-Clinical Trials for Patients with Invisible Illnesses
(1888PressRelease) Dr. Diana Driscoll, President of Genetic Disease Investigators, LLC., in conjunction with Total Eye Care, is beginning FREE pre-clinical trials in search of a cure for "Invisible Illnesses". These may include Chronic Fatigue Syndrome, Multiple Sclerosis, Ehlers-Danlos syndrome with Dysautonomia, Rheumatoid Arthritis, Endometriosis, and Chronic Lyme Disease.
Doctors Holding Free Pre-Clinical Trials for Patients with Invisible Illnesses (1888PressRelease) Dr. Diana Driscoll, President of Genetic Disease Investigators, LLC., in conjunction with Total Eye Care, is beginning FREE pre-clinical trials in search of a cure for "Invisible Illnesses". These may include Chronic Fatigue Syndrome, Multiple Sclerosis, Ehlers- Danlos syndrome with Dysautonomia, Rheumatoid Arthritis, Endometriosis, and Chronic Lyme Disease. Dallas, TX - Total Eye Care and Genetic Disease Investigators, LLC are pleased to announce their dedication to discovering a cure for "invisible illnesses" by offering free pre-clinical trial testing to patients affected by these diseases. Invisible illnesses can best be described as illnesses that yield very valid symptoms, yet have often been misunderstood and misdiagnosed by the medical community at large. These include such diseases as Chronic Fatigue Syndrome (CFS or M.E.), Fibromyalgia, Ehlers-Danlos syndrome with Dysautonomia, Chronic Lyme Disease, Idiopathic Lung Fibrosis, Endometriosis, Rheumatoid Arthritis, and Multiple Sclerosis. The Center for Disease Control and Prevention identified that five million people in 2005 suffered from Fibromyalgia alone, and another 1 to 4 million were living with CFS, out of which less that 20% had actually been diagnosed. Sadly, these statistics are believed to be largely underestimated in regards to those truly affected by the diseases. Ten years ago, Dr. Diana Driscoll, now President of Genetic Disease Investigators, LLC was struck with one of these invisible illnesses, called Ehlers-Danlos syndrome with Dysautonomia. While enduring the suffering resulting from this condition, and while on professional disability, Dr. Driscoll dedicated her time and resources to the goal of discovering the cause of these illnesses, their common denominators, and a cure. She founded and currently oversees the websitehttp://www.prettyill.com. Here, the public can view much of her research and patients can gain support from her forum for fellow patients. As one of the patients commented, "Dr. Diana has opened up a whole new world of science and set me on a path of discovery to a point where everything finally made sense." Current clinical testing is being personally funded by Drs. Diana and Richard Driscoll - a groundbreaking approach to expediting clinical trials. This reflects their level of commitment to help individuals suffering from chronic illness. As Dr. Richard Driscoll commented, "Traditionally, applying for research grants and paying for large administrative costs not only slows research efforts, but can mean that the research is never completed. We knew that it was time to instigate a change." Dr. Diana Driscoll explained, "It wasn't until our children and I were affected by one of these "invisible illnesses" that I realized how little was understood about these potentially disabling conditions. Treatments were often directed at easing symptoms rather than hitting the source of the problem. While researching these conditions, I noticed that many of these "invisible illnesses" had similar co-morbid presentations. I was on a mission to find the source of the commonalities and treat the initial source of our problems." Genetic Disease Investigators, LLC, currently partnering with Total Eye Care, has begun preliminary clinical trial testing for these sufferers. The initial patient testing consists of a blood test ($800 value), a questionnaire, and ocular fundus photos ($125 value), all of which will be administered at NO COST to the patient. For additional information on these tests, please visit www.TotalEyeCare.com. And for information on similar clinical trials being offered by Genetic Disease Investigators, please visit www.Clinicaltrials.gov. The deadline for participating in this clinical trial pretesting is Friday, December 28, 2012. If you or a loved one has been diagnosed with one or more of the diseases listed above, please contact Clinical_Trials ( @ ) Prettyill dot com dot Contact Information: Diana Driscoll, President Genetic Disease Investigators, LLC 817.723.6281 DrDiana ( @ ) Prettyill dot com http://www.prettyill.com/ ###